<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyTrialSummaryOutput xmlns:ns2="local" id="74156"><Title>Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer</Title><Indications><Indication>Metastatic colorectal cancer</Indication></Indications><Phase>Phase 3 Clinical</Phase><Drugs><Drug>bevacizumab</Drug><Drug>capecitabine</Drug><Drug>oxaliplatin</Drug></Drugs><RecruitmentStatus>Terminated</RecruitmentStatus><Sponsor>Cancer and Leukemia Group B</Sponsor></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyTrialSummaryOutput>